GPT-Rosalind 提出神经退行性疾病新线索:恢复胆固醇转运或可保护神经元
摘要
OpenAI 称 GPT-Rosalind 在药物发现中提出一条新线索:恢复胆固醇转运是否可能保护神经元免于退化。与 Perry 综合征相关的基因 DCTN1 在小鼠脑数据中被破坏后,参与胆固醇合成的基因表达上升,GPT-Rosalind 据此推测胆固醇可能没有到达神经元所需的位置,为科学家提供了可检验的具体机制。
摘要由模型根据原文撰写,以原文为准。
正文 · 原文
GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?
DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it.
That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders.
With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets.
https://openai.com/index/scaling-ai-research-for-complex-biological-data/
来源:OpenAI · x.com
引用原文
OpenAI. GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?[EB/OL]. (2026-10-21)[访问日期]. https://x.com/OpenAI/status/2112899854569762936.